AQR Capital Management
ORGO icon

AQR Capital Management’s Organogenesis Holdings ORGO Stock Holding History

AQR Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.32M Buy
3,011,753
+2,130,036
+242% +$5.2M ﹤0.01% 1762
2026
Q1 		$2.09M Buy
881,717
+240,194
+37% +$832K ﹤0.01% 2317
2025
Q4 		$3.32M Sell
641,523
-65,245
-9% -$316K ﹤0.01% 1820
2025
Q3 		$2.98M Sell
706,768
-10,304
-1% -$47.9K ﹤0.01% 1744
2025
Q2 		$2.62M Sell
717,072
-176,695
-20% -$659K ﹤0.01% 1622
2025
Q1 		$3.86M Sell
893,767
-628,387
-41% -$2.54M ﹤0.01% 1258
2024
Q4 		$4.87M Sell
1,522,154
-1,188,452
-44% -$3.99M 0.01% 1112
2024
Q3 		$7.75M Buy
2,710,606
+441,846
+19% +$1.24M 0.01% 885
2024
Q2 		$6.35M Buy
2,268,760
+986,132
+77% +$2.65M 0.01% 922
2024
Q1 		$3.64M Buy
1,282,628
+91,635
+8% +$311K 0.01% 1126
2023
Q4 		$4.87M Sell
1,190,993
-351,767
-23% -$985K 0.01% 964
2023
Q3 		$4.91M Sell
1,542,760
-133,173
-8% -$423K 0.01% 935
2023
Q2 		$5.56M Sell
1,675,933
-876,280
-34% -$2.59M 0.01% 861
2023
Q1 		$5.44M Buy
2,552,213
+361,648
+17% +$893K 0.01% 852
2022
Q4 		$5.89M Buy
2,190,565
+902,291
+70% +$2.63M 0.01% 821
2022
Q3 		$4.17M Buy
1,288,274
+943,251
+273% +$4.26M 0.01% 896
2022
Q2 		$1.68M Buy
345,023
+188,963
+121% +$1.16M ﹤0.01% 1186
2022
Q1 		$1.19M Sell
156,060
-39,087
-20% -$303K ﹤0.01% 1450
2021
Q4 		$1.8M Buy
195,147
+116,971
+150% +$1.24M ﹤0.01% 1234
2021
Q3 		$1.11M Sell
78,176
-2,422
-3% -$37.6K ﹤0.01% 1478
2021
Q2 		$1.34M Buy
80,598
+64,711
+407% +$1.21M ﹤0.01% 1441
2021
Q1 		$289K Buy
+15,887
New +$215K ﹤0.01% 2020

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management's ORGO Position: Q2 2026 in Review

AQR Capital Management increased its Organogenesis Holdings (ORGO) stake by 242% in Q2 2026, buying an estimated $5.2M and bringing the position to 3,011,753 shares worth $7.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

AQR Capital Management first reported a position in ORGO in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.75M in Q3 2024. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • AQR Capital Management held 3,011,753 shares of Organogenesis Holdings worth $7.32M as of Q2 2026.
  • AQR Capital Management bought 2,130,036 Organogenesis Holdings shares in Q2 2026, an estimated $5.2M.
  • Organogenesis Holdings made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #1762 holding.
  • AQR Capital Management first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 22 quarters since.
  • AQR Capital Management's Organogenesis Holdings position peaked at $7.75M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.